Clinical Trial Update: Prevention of Early Readmission in Elderly Congestive Heart Failure Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial sponsored by NHLBI evaluating strategies to prevent early readmission in elderly patients with congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 2 | Status: COMPLETED